Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database

PURPOSE: To compare the rate of biologic initiation after commencing treatment with apremilast (APR) vs methotrexate (MTX), in systemic-naïve patients with psoriatic arthritis (PsA). PATIENTS AND METHODS: Systemic-naïve patients with PsA who started treatment with either APR or MTX between 01/01/201...

Descripción completa

Detalles Bibliográficos
Autores principales: Husni, M Elaine, Chang, Eunice, Broder, Michael S, Paydar, Caleb, Bognar, Katalin, Desai, Pooja, Klyachkin, Yuri, Khilfeh, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207121/
https://www.ncbi.nlm.nih.gov/pubmed/35734243
http://dx.doi.org/10.2147/OARRR.S342123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207121/
https://www.ncbi.nlm.nih.gov/pubmed/35734243
http://dx.doi.org/10.2147/OARRR.S342123

Ejemplares similares